These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8032634)

  • 1. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel inhibitory prostanoid receptor in piglet saphenous vein.
    Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
    Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
    Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
    Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J
    Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors.
    Coleman RA; Sheldrick RL
    Br J Pharmacol; 1989 Mar; 96(3):688-92. PubMed ID: 2720298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS; Jones RL
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
    Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
    Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
    Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
    Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
    Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
    Lawrence RA; Jones RL
    Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
    Crankshaw DJ; Gaspar V
    J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the characterisation of prostanoid receptors: a proposed classification.
    Kennedy I; Coleman RA; Humphrey PP; Levy GP; Lumley P
    Prostaglandins; 1982 Nov; 24(5):667-89. PubMed ID: 6131499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade.
    Jones RL; Wilson NH; Lawrence RA
    Br J Pharmacol; 1989 Apr; 96(4):875-87. PubMed ID: 2743082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.